Jiangsu Aidea Pharmaceutical Group Co., Ltd. Class ASSE: 688488

"JIANGSU AIDEA PHARMACEUTICAL GROUP CO., LTD."Announcement on Failure to Satisfy Exercise Conditions for the 1st Exercise Period under the 2025 Stock Option Incentive Plan and Cancellation of Certain Stock Options

Aug 29, 2026 · Issued by Jiangsu Aidea Pharmaceutical Group Co., Ltd. Class A via Shanghai Stock Exchange

Announcement on Failure to Satisfy Exercise Conditions for the 1st Exercise Period under the 2025 Stock Option Incentive Plan and Cancellation of Certain Stock Options

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis

Earlier from Jiangsu Aidea Pharmaceutical Group Co., Ltd. Class A

"JIANGSU AIDEA PHARMACEUTICAL GROUP CO., LTD."Announcement on Pledge of Certain Shares Held by Persons Acting in Concert with the Actual ControllerAug 19
"JIANGSU AIDEA PHARMACEUTICAL GROUP CO., LTD."Announcement on Results of Shareholding Increase by the Actual ControllerAug 14
"JIANGSU AIDEA PHARMACEUTICAL GROUP CO., LTD."Announcement on Progress of Acquisition of the Minority Shareholder's Equity Interests in Controlled SubsidiaryAug 13
"JIANGSU AIDEA PHARMACEUTICAL GROUP CO., LTD."Announcement on Use of Own Funds, Bank Acceptance Bills and Other Methods to Pay Funds Required for Raised Fund Investment Projects and Equivalent Replacement with Raised FundsJul 31

All Jiangsu Aidea Pharmaceutical Group Co., Ltd. Class A news releases